Piper Sandler Upgrades Tandem Diabetes Care (TNDM) to Overweight
Piper Sandler analyst Matt O'Brien upgraded Tandem Diabetes Care (NASDAQ: TNDM) from Neutral to Overweight with a price target of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
